Gilead Sciences is a leading biopharmaceutical company that seeks to advance the care of patients living with
HIV and other diseases by developing new products in these areas. With a goal of simplifying HIV therapy for the millions of people living with the disease worldwide, Gilead offers several therapies that are dosed as a single pill, once daily as part of a combination HIV
regimen.
To learn more about our HIV products, click on the logos below.
Patients should read the Patient Information, including "What is the most important information I should know about ATRIPLA, TRUVADA and EMTRIVA?" or "What are the possible side effects of VIREAD?"
. .. .
. . . .
